Image

Breast Cancer-Related Approach for Increasing Cervical Cancer Screening

Breast Cancer-Related Approach for Increasing Cervical Cancer Screening

Recruiting
50-74 years
Female
Phase N/A

Powered by AI

Overview

The primary objective of this clinical trial is to assess cervical cancer screening participation among under-screened women invited through organized breast cancer screening programs in Switzerland.

This randomized trial will compare three arms:

  1. Intervention group 1: Sensitization to Cervical Cancer (CC) screening Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment.
  2. Intervention group 2: Home-based Human papillomavirus infection (HPV) self-sampling Women will receive a free-of-charge vaginal self-sampling kit for HPV infection
  3. Observational control group Women selected in the control arm will only be recruited one year following the screening of those in the intervention arm (T0+1), as to not influence Cervical Cancer Screening (CCS) behavior during this period by being reminded of screening recommendations.

Description

Secondary objectives are:

  • To identify and compare the association of socio-demographic characteristics with screening participation in all study arms (cf. 3.2 study design).
  • To compare the use of primary screening methods (HPV test vs. Papanicolaou test) between study arms.
  • To compare prevalence of positive primary screening and triage results between study arms.
  • To compare follow-up rates for participants screened positive in both intervention arms.
  • To evaluate acceptability of both screening strategies (sensitization vs. home-based).
  • To assess the relationship between CCS behavior and Breast Cancer Screening (BCS) behavior.

Eligibility

Inclusion Criteria:

  • Women receiving Breast Cancer Screening (BCS) invitation letters in the selected five cantons (Geneva, Bern (francophone), Jura, Neuchâtel, and Vaud)
  • Aged 50 to 74 years old
  • Not been screened for cervical cancer in the past three years
  • Speaking one of the 6 languages of the study (French, German, Italian, and in English, Spanish, and Portuguese)

Exclusion Criteria:

  • Prior cervical cancer diagnosis,
  • Hysterectomy
  • Non consent to participate to the study
  • Incapable of judgment or under tutelage
  • Pregnancy

Study details
    Cervical Cancer Screening

NCT07171658

Jessica Di Vincenzo Sormani

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.